2016
DOI: 10.1074/jbc.m115.691550
|View full text |Cite
|
Sign up to set email alerts
|

GIV/Girdin (Gα-interacting, Vesicle-associated Protein/Girdin) Creates a Positive Feedback Loop That Potentiates Outside-in Integrin Signaling in Cancer Cells

Abstract: Activation of the tyrosine kinase focal adhesion kinase (FAK) upon cell stimulation by the extracellular matrix initiates integrin outside-in signaling. FAK is directly recruited to active integrins, which enhances its kinase activity and triggers downstream signaling like activation of PI3K. We recently described that G␣-interacting, vesicle-associated protein (GIV), a protein up-regulated in metastatic cancers, is also required for outside-in integrin signaling. More specifically, we found that GIV is a non-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
30
0

Year Published

2016
2016
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 25 publications
(31 citation statements)
references
References 55 publications
1
30
0
Order By: Relevance
“…As for the impact of the GIV•K2 interaction on GIV biology, findings showcased here, together with our understanding of how GIV modulates integrin/FAK signaling via G protein intermediates (Leyme et al, 2016;Leyme et al, 2015;Lopez-Sanchez et al, 2015), provide a more complete mechanistic insight into the roles of GIV in both early and late steps of integrin signaling [Fig 7A]. Because integrin signaling aids cancer growth, metastasis, and drug resistance, the signaling interfaces assembled by GIV (GIV•K2 and GIV•Gαi) provide new strategies for targeting the integrin pathway.…”
Section: Resultsmentioning
confidence: 79%
See 4 more Smart Citations
“…As for the impact of the GIV•K2 interaction on GIV biology, findings showcased here, together with our understanding of how GIV modulates integrin/FAK signaling via G protein intermediates (Leyme et al, 2016;Leyme et al, 2015;Lopez-Sanchez et al, 2015), provide a more complete mechanistic insight into the roles of GIV in both early and late steps of integrin signaling [Fig 7A]. Because integrin signaling aids cancer growth, metastasis, and drug resistance, the signaling interfaces assembled by GIV (GIV•K2 and GIV•Gαi) provide new strategies for targeting the integrin pathway.…”
Section: Resultsmentioning
confidence: 79%
“…Next we asked how the newly defined GIV•kindlin-2 interaction impact cellular phenotypes. Prior studies have shown that GIV is required for signal amplification downstream of ligand-activated β 1-integrins via its ability to directly bind and activate Gαi and Class 1 PI3-kinase; the readouts used were cell adhesion and spreading, haptotaxis, activation of the PI3K→Akt, FAK→pY1764GIV and RhoA→myosin light chain (MLC2) signaling axes, the degree of maturation of FAs with sequential recruitment of paxillin and vinculin proteins and activation of FAK (Leyme et al, 2016;Leyme et al, 2015;Lopez-Sanchez et al, 2015). If these downstream events were dependent on GIV's ability to bind ligand-activated β 1-integrins, we hypothesized that uncoupling GIV from β 1-integrins will impair them all.…”
Section: The Giv•kindlin-2 Interaction Enhances Tumor Cell Adhesionmentioning
confidence: 99%
See 3 more Smart Citations